trimethoprim has been researched along with Egyptian Ophthalmia in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nisbet, IT | 1 |
| Graham, DM | 1 |
| Spicer, PE | 1 |
| Tibbs, GJ | 1 |
1 trial available for trimethoprim and Egyptian Ophthalmia
| Article | Year |
|---|---|
Chlorhexidine as an effective agent against Chlamydia trachomatis in vitro and in vivo.
Topics: Child, Preschool; Chlamydia trachomatis; Chlorhexidine; HeLa Cells; Humans; Placebos; Sulfamethoxazo | 1979 |